SRNE vs. CELZ, TTNP, PALI, NSTGQ, FRTX, IKT, ONVO, TCON, BCDA, and GENE
Should you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include Creative Medical Technology (CELZ), Titan Pharmaceuticals (TTNP), Palisade Bio (PALI), NanoString Technologies (NSTGQ), Fresh Tracks Therapeutics (FRTX), Inhibikase Therapeutics (IKT), Organovo (ONVO), TRACON Pharmaceuticals (TCON), BioCardia (BCDA), and Genetic Technologies (GENE). These companies are all part of the "biological products, except diagnostic" industry.
Sorrento Therapeutics (NASDAQ:SRNE) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, community ranking, media sentiment, dividends, institutional ownership, valuation and profitability.
Sorrento Therapeutics has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.22, meaning that its share price is 122% more volatile than the S&P 500.
0.0% of Sorrento Therapeutics shares are owned by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by insiders. Comparatively, 3.3% of Creative Medical Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Sorrento Therapeutics received 539 more outperform votes than Creative Medical Technology when rated by MarketBeat users. Likewise, 70.93% of users gave Sorrento Therapeutics an outperform vote while only 68.93% of users gave Creative Medical Technology an outperform vote.
In the previous week, Creative Medical Technology had 7 more articles in the media than Sorrento Therapeutics. MarketBeat recorded 8 mentions for Creative Medical Technology and 1 mentions for Sorrento Therapeutics. Creative Medical Technology's average media sentiment score of 0.24 beat Sorrento Therapeutics' score of 0.00 indicating that Creative Medical Technology is being referred to more favorably in the news media.
Sorrento Therapeutics' return on equity of 0.00% beat Creative Medical Technology's return on equity.
Creative Medical Technology has lower revenue, but higher earnings than Sorrento Therapeutics.
Summary
Creative Medical Technology beats Sorrento Therapeutics on 7 of the 12 factors compared between the two stocks.
Get Sorrento Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRNE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sorrento Therapeutics Competitors List
Related Companies and Tools
